dase, an enzyme that effectively reduces lipid peroxides. No changes in lipid peroxidation, in response to the H 2 -blocker, were observed, however its accumulation in the vicinity of vacuole-like structures was specific to proton pump inhibition. This finding suggests that lipid peroxidation occurs in local parietal cells.
I. Introduction
Gastric parietal cells synthesize and secrete hydrochloric acid (acid). Ultrastructurally, the intracellular membrane system from the intracellular tubular vesicles to the intracellular secretory canaliculus has been found to change dynamically in association with acid secretion [14] . Over the past several years it has been reported that both singlet-oxygen scavenger superoxide dismutase (SOD) and glutathioneperoxidase (GSH-PO), the most effective lipid peroxide scavenger, are present in large amounts in the parietal cells of the gastric mucosa [14, 19] . It has been postulated that there is an association between peroxidation and dynamic changes in the intracellular membrane system. Recently in the clinical setting, proton pump inhibitors and H 2 -blockers have been widely used as powerful acid secretion inhibitors. Investigating the association between these drugs and lipid peroxidation should prove useful in elucidating the relationship between the acid secretion phenomenon and lipid peroxidation as well as help understand the drug properties.
We investigated the effect of an H 2 -blocker (roxatidine acetate hydrochloride) and a proton pump inhibitor (Omeprazole), acid secretion inhibitors known to have different mechanisms of action, on parietal cell lipid peroxidation. Enzyme activity and lipid peroxides were measured using both immunohistocytochemical localization with antibodies to the lipid peroxide scavenger GSH-PO as well as biochemical means (TBA values).
II. Materials and Methods

Animals and drugs
Ten-week-old female SD rats were purchased from Charles River Japan (Atsugi, Japan). Histamine was obtained from Wako Pure Chemical Industries, Ltd., roxatidine acetate hydrochloride from Teikoku Hormon Mfg. Co., Ltd., and Omeprazole from Yoshitomi Pharmaceutical Ind., Ltd.
Experiments 1) Single-dose administration
Histamine was administered as a single oral dose (0.5 mg/kg) to the acid secretagogue group serving as the maximal acid secretion dose [15] , while a single oral dose of roxatidine acetate hydrochloride, 300 mg/kg, or Omeprazole, 32 mg/kg, was administered to the acid secretion inhibition group. Doses were adjusted in order to provide approximately the same degree of acid secretion inhibition [7, 21] . The animals were killed 2 hr after histamine administration and 2, 4, 6, and 10 hr after the administration of the other drugs.
2) Histamine + acid secretion inhibitor single dose group
Models were created in which each of the acid secretion inhibitors was administered in a single dose during continual administration of histamine as a means of rapidly activating the intracellular membrane system. More specifically, repeated subcutaneous injections of histamine, 0.5 mg/kg in 2-hr intervals, and 1 hr after the first dose the same as in 1), a single oral dose of roxatidine acetate hydrochloride (300 mg/kg) or Omeprazole (32 mg/kg), was administered. The animals were then killed in the same manner as above.
3) Repeated oral administration of acid secretion inhibitors
Oral doses of roxatidine acetate hydrochloride, 300 mg/ kg, or Omeprazole, 32 mg/kg, were administered repeatedly, once daily. Animals were then killed 1, 2, 3, and 4 weeks after the start of drug administration.
4) Isolated parietal cell study
Ten-week-old female SD rats were purchased from Charles River Japan (Atsugi, Japan). Reversed stomachs were prepared according to the method of Tani et al. [6, 10] and incubated for 30 min at 37°C under an atmosphere of 95% O2 and 5% CO2 in 0.2% pronase E (Sigma Chemical Co., St. Louis, MO) + Cell Medium 199 (Sigma Chemical Co., St. Louis, MO). The parietal cells were isolated and 10 -4 M Omeprazole, the concentration that maximally inhibits acid secretion, was added to the obtained cell suspension. After incubating for 20 min at 37°C, the suspension was compressed onto a glass slide by Cytospin (Cytospin 2, Shandon Co.) at 800 rpm for 15 min, and then morphological observations were recorded [5, 6] .
Immunocytochemical studies 1) In vivo experiments
The stomach was incised along the greater curvature and a portion of the gastric body was fixed with periodate lysine 4% paraformaldehyde solution (4% PLP solution) at 4°C for 3 hr [13] . After fixation the tissue was thoroughly washed with 0.01 M phosphate-buffered saline (PBS, pH 7.4) to which 20% sucrose had been added. Next tissues were embedded in OCT compound and then 6-mm serial frozen sections were prepared with a cryostat. After thorough washing with the 0.01 M PBS, the frozen sections were reacted with direct-method horseradish peroxidase-labeled anti-GSH-PO antibody IgG Fab for 3 hr at room temperature [16, 22, 24] . Anti-GSH-PO was kindly provided by Professor Keiichi Watanabe, Department of Pathology, Tokai University School of Medicine, Kanagawa, Japan. After the reaction was complete and the sections thoroughly washed with 0.01% PBS, Graham-Karnovsky's reaction medium, which contained 0.05% H 2 O 2 , was used for the color reaction. Once nuclear staining with 1% methyl green was complete, the slides were sealed for light microscopy [3] . For electron microscopy, after color development with the same solution as above, the sections were post-fixed with 2% OsO 4 solution for 1 hr, dehydrated in an ethanol series and embedded by the Epon inversion method. The Epon blocks were then re-trimmed, where ultrathin sections were prepared with an LKB-ultramicrotome and examined with a JEOL-1200EX transmission electron microscope.
For routine electron microscopy, after fixation for 3 hr with 2.5% glutaraldehyde and post-fixation for 1 hr with 1% OsO 4 , the specimens were washed with phosphate buffer and dehydrated through a graded ethanol series. Next they were embedded in Epon where ultrathin sections were prepared in the same manner as above and examined with an electron microscope.
2) Isolated parietal cell study
After incubating isolated parietal cells with each of the drugs, they were compressed onto slide glasses by cytospin (800 rpm, 15 min). The cells were then fixed in 4% PLP for 1 hr, in the same manner as the tissue, and then washed with 0.01 M phosphate buffer. The results of immunohistocytochemical staining with anti-GSH-PO antibody were examined using both light and electron microscopy. In addition, after fixing for 3 hr with 2.5% glutaraldehyde and post-fixation for 1 hr with 1% osmic acid, and dehydratation through a graded ethanol series, they were embedded in Epon. Ultrathin sections were prepared in the same manner as above, electron-stained with uranium and lead, and examined with an electron microscope.
Biochemical studies 1) Measurement of GSH-PO activity
The stomachs collected from the animals in experimental groups 2 and 3 were 10% homogenized with 25 mM Tris HCl, and as previously described enzyme activity was measured by the NADPH disappearance rate [11] .
2) Measurement of lipid peroxides (TBA value)
The stomachs collected from the animals in experimental groups in 2 and 3 were 10% homogenized with 25 mM Tris HCl, and lipid peroxides were measured using the Thiobarbital acid (TBA) method [10] .
Statistical analysis
The data were expressed as the mean±SE. Statistical analysis was performed by the unpaired t-test, and p<0.05 was considered significant.
III. Results
Immunocytochemical studies
Control group: GSH-PO revealed diffuse staining of relatively large cells, which is suggestive of parietal cells (Fig. 1 ). The specific reaction in gastric cells was not observed at all by normal rabbit serum (NRS) conducted as a control test. Examination of the immunoelectron microscopy preparations showed diffuse localization of GSH-PO in the cytoplasm of the parietal cells, with no staining in the lumens of the endoplasmic reticulum or mitochondria (Fig. 2 ).
1) Single-dose study
Examination of the light microscopy preparations in the histamine group, the roxatidine acetate hydrochloride group, and Omeprazole group showed GSH-PO staining localized to gastric parietal cells alone with no clear differences in staining intensity ( Fig. 3A-C) . Electron microscopy in the histamine group revealed that the intracellular secretory canaliculus had developed considerably, with many cells exhibiting the stimulating stage reported by Black et al. [1] . The immunoelectron microscopy preparations showed GSH-PO predominantly localized in the vicinity of the highly developed secretory canaliculus. The electron microscopic examination, 2 hr after roxatidine acetate hydrochloride administration, showed prominent tubular vesicles in many of the parietal cells, indicative of the resting stage, with no marked changes in GSH-PO localization sites or staining intensity ( Fig. 4 ). Immunoelectron microscopy 2 hr after Omeprazole administration showed more prominent intra-cellular secretory canaliculus than in the roxatidine acetate hydrochloride group. Vacuole-like structures were observed within the cells, a characteristic phenomenon. GSH-PO was localized in the cytoplasm, similar to the control and the roxatidine acetate hydrochloride groups described above, but its accumulation in the vicinity of the vacuole-like structures was specific. Moreover, the vacuole-like structures increased with time, some of them fused, and their accumulation of GSH-PO also became more prominent (Fig. 5 ).
2) Histamine + roxatidine acetate hydrochloride and Omeprazole
The stimulating stage was observed in the histaminealone repeated-dose group, similar to that in the single-dose histamine group described above, but no changes in GSH-PO localization or staining intensity were observed as a result of repeated administration, under light or electron microscopy. In the histamine administered in advance, repeated-dose histamine + single-dose roxatidine acetate hydrochloride group, acid secretion was rapidly inhibited and morphologically the stimulating stage was converted to the resting stage when the single dose of roxatidine acetate hydrochloride was administered. The intracellular membrane system was activated but there were no clear changes in GSH-PO staining. In the histamine in advance, repeateddose histamine + single-dose Omeprazole group, in contrast to the roxatidine acetate hydrochloride, no morphological changes were observed from the stimulating stage, a state of acid secretion ultrastructurally, to the resting stage. However, intracellular vacuole-like structures appeared, similar to single dose Omeprazole administration, and GSH-PO was observed to accumulate in the vicinity of the vacuole-like structures. 
3) Repeated administration
Many cells were observed to be in the resting stage in the roxatidine acetate hydrochloride repeated-dose group, similar to the single-dose group, but no clear morphological changes or changes in GSH-PO staining were observed. The intracellular vacuole-like structures were more prominent in the repeated-dose Omeprazole group than in the single-dose group, but GSH-PO was observed to have accumulated in the vicinity of the vacuole-like structures. This localization was observed in a similar manner in response to repeated administration.
4) Isolated parietal cell study
In the isolated parietal cells, diffuse localization of GSH-PO was observed under light microscopy in the cytoplasm of large cells suggesting parietal cells (Fig. 6A ). Under the electron microscopic there was diffuse GSH-PO staining in the cytoplasm of the parietal cells (Fig. 7) . In the Omeprazole group light microscopy revealed intense staining, similar to the control group (Fig. 6B ). Electron microscopically, intracellular vacuole-like structures were observed in the parietal cells, similar to that observed in vivo, and GSH-PO accumulation in the vicinity of the vacuole-like structures was observed similar to the immunoelectron microscopy observations (Fig. 8 ).
Fig. 3. Examination of the light microscopy preparations in the histamine group (A), the roxatidine acetate hydrochloride group (B), and the
Omeprazole group (C) showed GSH-PO staining localized to the gastric parietal cells alone, with no clear differences in the intensity of the staining.´200. Fig. 4 . The electron microscopic examination 2 hr after roxatidine acetate hydrochloride administration showed prominent tubular vesicles, i.e., the resting stage, in many of the parietal cells, with no marked changes in GSH-PO localization sites or staining intensity.´5000.
Biochemical studies Measurements of GSH-PO activity 1) Histamine + single-dose administration of an acid secretion inhibitor
When the H2-blocker (roxatidine acetate) was administered, GSH-PO activity was not significantly different from the repeated histamine administration group, but it was significantly lower in the Omeprazole group (Fig. 9) .
2) Repeated-dose administration of acid secretion inhibitors
No significant differences in GSH-PO activity were observed as the result of repeated administration of either roxatidine or Omeprazole (Fig. 10) .
Lipid peroxide measurements 1) Histamine + single-dose acid secretion inhibitor administration groups
No significant differences in lipid peroxide levels were observed in either the roxatidine group or the Omeprazole group (Fig. 11) .
2) Repeated-dose acid secretion inhibitor groups
There were no significant differences between either the roxatidine or Omeprazole group and the control group (Fig. 12 ).
Fig. 5.
Immunoelectron microscopy 2 hr after Omeprazole administration showed more prominent intracellular secretory tubules than in the roxatidine acetate hydrochloride group, and vacuole-like structures were observed within the cells as a characteristic phenomenon. GSH-PO was localized in the cytoplasm, the same as in the control group and the roxatidine acetate hydrochloride group described above, but its accumulation in the vicinity of the vacuole-like structures was a specific finding. Moreover, the vacuole-like structures increased over time, some of them were seen to fuse, and their accumulation of GSH-PO also became more clearly prominent.´5000. 
IV. Discussion
Morphologically, the intracellular membrane system of gastric parietal cells changes very dynamically from intracellular tubular vesicles to secretory canaliculus when they synthesize and secrete hydrochloric acid, thus there is suggestive evidence that membrane lipid peroxidation, especially peroxidation of the unsaturated phospholipid fatty acids, is readily induced. For this reason, large amounts of GSH-PO, the most effective lipid peroxide reducing enzyme, is also assumed to be present. In this study GSH-PO was only observed in the cytoplasm of gastric parietal cells, however small amounts are generally observed in the mitochondria as well. Since it is present in such small amounts, it is suggested that mitochondrial GSH-PO is difficult to detect by the ordinary immunoelectron microscopy procedures we have used for immunocytochemistry until now, thus additional studies will be needed to detect this. Murakoshi et al. [14] reported that GSH-PO in the rat stomach is localized in parietal cells, associating this localization with the state of acid secretion. Changes in response to histamine and atropine administration by immunoelectron microscopy were then investigated. Since GSH-PO staining by parietal cells increased after histamine stimulation and decreased after atropine stimulation, Murakoshi et al. reported that parietal cell GSH-PO was responsible for reducing lipid peroxides, which are generated for the most part in association with acid secretion. The present experiment examined changes in parietal cells in response to single, repeated doses, and combinations of acid secretagogues and acid secretion inhibitors, focusing on immunoelectron microscopic observations of GSH-PO. Histamine was chosen as the acid secretagogue, while a H 2 -blocker and proton pump inhibitor, which have different mechanisms of action, were chosen as the acid secretion inhibitors. During the state of acid secretion promotion, by administering histamine alone in repeated doses, marked development of the intracellular secretory canaliculus was observed. GSH-PO was also observed in the cytoplasm in the vicinity of the organelles, corroborating the above-described findings reported by Murakoshi et al. [4, 18] . In contrast, when acid secretion was inhibited by the H2-blocker, although forcibly converted from an acid-secreting state to an acid secretion-inhibited state by single and repeated administration, and the intracellular membrane system was activated and suddenly changed into the intracellular tubular vesicle from the intracellular secretory canaliculus, no changes in the localization or the intensity of the GSH- Fig. 9 . Histamine + single-dose administration of an acid secretion inhibitor. When the H2-blocker roxatidine was administered, GSF-PO activity was not significantly different from the repeated histamine administration group, but it was significantly lower in the Omeprazole group. PO staining were observed with the immunoelectron microscope. Thus no effect on lipid peroxidation was associated with administration of the H 2 -blocker, and it did not appear to induce injurious morphological changes. When the proton pump inhibitor Omeprazole was administered, however, in contrast to the H 2 -blocker above, the acid secretion state did not show a state of acid secretion inhibition morphologically. The parietal cells possessing vacuole-like structures, their characteristic change, were observed in all of the experimental systems in the present study, i.e. when unstimulated, when stimulated with histamine, and when administered repeatedly. The intracellular secretory canaliculus found possessed these vacuole-like structures thus it was suspected the intracellular secretory canaliculus changed. GSH-PO accumulation was observed in the vicinity of the above structures when the H 2 -blocker was administered, a result that contrasted with those mentioned above. The observation that GSH-PO was localized in the vicinity of the vacuole-like structures may mean that lipid peroxide synthesis is induced in the vicinity of the vacuole-like structures. These findings suggest that individual intracellular scavenger enzymes such as GSH-PO and lipid peroxides may change when acid secretion is physiologically inhibited, however it appears impossible to make quantitative judgments based on the results of an immunohistocytochemical study. In the biochemical study, when changes in lipid peroxides in the stomach as a whole were examined, it was found that GSH-PO tended to be increased in states in which acid secretion was promoted when compared with groups in which acid secretion was inhibited. In contrast, GSH-PO activity did not change as a result of inhibition of acid secretion by the acid secretion inhibitors. In addition, no change in the amount of lipid peroxides was observed even in response to repeated administration of the proton pump inhibitor, which immunohistochemically appeared to induce local lipid peroxidation. As I mentioned above, both the change in GSH-PO activity and that in the amount of lipid peroxides could be observed in each cell. However, since the quantity of the experiment was quite fixed, these changes did not influence the whole stomach, and therefore, it was very difficult to find these changes in the cellular level when examing the whole stomach. GSH-PO is an enzyme with a relatively rapid turnover, and there are many studies that report it migrates relatively rapidly to places where lipid peroxides have appeared [2, 17, 23] . In parietal cells, after administration of Omeprazole, vacuolar degeneration, cell necrosis, increased cell turnover in the stomach, and hypertrophy and hyperplasia of the gastric glands have been reported [8, 9] . Our present finding, that similar morphological changes were also observed in vitro strongly suggests intracellular vacuolar structures represent a direct effect of Omeprazole. This vacuolization may indicate degenerative damage to parietal cells, and suggests induced local lipid peroxidation. In the future more detailed studies will be possible through the investigation of SOD catalase activation in parietal cells.
V. Conclusions
1. The H2-blocker had no effect on the lipid peroxide elimination system.
2. With the proton pump inhibitor, vacuole-like structures were observed in all of the experimental groups. These were also seen in the in vitro system, in which isolated cells were used. Thus the appearance of vacuole-like structures associated with Omeprazole strongly suggests a direct action of the drug.
3. Local lipid peroxidation reactions appeared to be induced by vacuole formation associated with administration of the proton inhibitor, however the problem of lipid peroxidation induction in the stomach as a whole is thought to be small.
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